Medical Dosimetry
Volume 35, Issue 3 , Pages 169-178 , Autumn 2010

Beams Arrangement in Non-Small Cell Lung Cancer (NSCLC) According to PTV and Dosimetric Parameters Predictive of Pneumonitis

  • Sara Ramella, M.D.

      Affiliations

    • Radiotherapy Unit, Campus Bio-Medico University, Rome, Italy
    • Corresponding Author InformationReprint requests to: Sara Ramella, M.D., Via E. Longoni 47, 00155, Rome, Italy
    • ,
  • Lucio Trodella, M.D.

      Affiliations

    • Radiotherapy Unit, Campus Bio-Medico University, Rome, Italy
    • ,
  • Tommaso Claudio Mineo, M.D.

      Affiliations

    • Department of Thoracic Surgery, Policlinico Tor Vergata University, Rome, Italy
    • ,
  • Eugenio Pompeo, M.D.

      Affiliations

    • Department of Thoracic Surgery, Policlinico Tor Vergata University, Rome, Italy
    • ,
  • Maria A. Gambacorta, M.D.

      Affiliations

    • Department of Radiation Therapy, Catholic University, Rome, Italy
    • ,
  • Francesco Cellini, M.D.

      Affiliations

    • Radiotherapy Unit, Campus Bio-Medico University, Rome, Italy
    • ,
  • Marzia Ciresa, M.D.

      Affiliations

    • Radiotherapy Unit, Campus Bio-Medico University, Rome, Italy
    • ,
  • Michele Fiore, M.D.

      Affiliations

    • Radiotherapy Unit, Campus Bio-Medico University, Rome, Italy
    • ,
  • Carlo Greco, M.D.

      Affiliations

    • Radiotherapy Unit, Campus Bio-Medico University, Rome, Italy
    • ,
  • Diego Gaudino, Ph.D.

      Affiliations

    • Radiotherapy Unit, Campus Bio-Medico University, Rome, Italy
    • ,
  • Gerardina Stimato, Ph.D.

      Affiliations

    • Radiotherapy Unit, Campus Bio-Medico University, Rome, Italy
    • ,
  • Angelo Piermattei, Ph.D.

      Affiliations

    • Department of Physics, Catholic University, Rome, Italy
    • ,
  • Alfredo Cesario, M.D.

      Affiliations

    • CdC San Raffaele, Velletri, Italy
    • Department of Thoracic Surgery, Catholic University, Rome, Italy
    • ,
  • Rolando M. D'Angelillo, M.D.

      Affiliations

    • Radiotherapy Unit, Campus Bio-Medico University, Rome, Italy

Received 5 September 2008 ,Accepted 5 May 2009.

References 

  1. Cox JD, Sause WT, Byhardt RW, et al. Dose intensity of radiation therapy in non-small cell carcinoma of the lung: a review of RTOG data and strategies. Lung. Cancer. 1994;(Suppl 1):S161–S166
  2. Langer CJ. The emerging role of gemcitabine in combination with radiation in locally advanced, unresectable non-small-cell lung cancer. Clin. Lung. Cancer. 2003;(Suppl 2):S45–S49
  3. Perez CA, Brady LW. Principles of Radiation Therapy. 2nd ed. Philadelphia: Lippincott Co; 1992;
  4. Arriagada R, Le Chevalier T, Quoix E, et al. ASTRO (American Society for Therapeutic Radiology and Oncology) plenary: Effect of chemotherapy on locally advanced non-small cell lung carcinoma: a randomized study of 353 patients. GETCB (Groupe d'Etude et Traitement des Cancers Bronchiques), FNCLCC (Federation Nationale des Centres de Lutte contre le Cancer) and the CEBI trialists. Int. J. Radiat. Oncol. Biol. Phys. 1991;20:1183–1190
  5. Armstrong JG, McGibney C. The impact of three-dimensional radiation on the treatment of non-small cell lung cancer. Radiother. Oncol. 2000;56:157–167
  6. Armstrong JG, Burman C, Leibel S, et al. Three-dimensional conformal radiation therapy may improve the therapeutic ratio of high dose radiation therapy for lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 1993;26:685–689
  7. Emami B, Purdy JA, Manolis J, et al. Three-dimensional treatment planning for lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 1991;21:217–227
  8. Mohan R, Mageras G, Wu Q. Computer-controlled delivery of 3D conformal radiation treatments. Cancer. Treat. Res. 1998;93:49–67
  9. Purdy JA. Three-dimensional treatment planning and conformal dose delivery—A physicist's perspective. Cancer. Treat. Res. 1998;93:1–34
  10. Yartsev S, Chen J, Yu E, et al. Comparative planning evaluation of intensity-modulated radiotherapy techniques for complex lung cancer cases. Radiother. Oncol. 2006;78:169–176
  11. Graham MV. Predicting radiation response. Int. J. Radiat. Oncol. Biol. Phys. 1997;39:561–562
  12. Graham MV, Jain NL, Kahn MG, et al. Evaluation of an objective plan-evaluation model in the three dimensional treatment of non small cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 1996;34:469–474
  13. Graham MV, Purdy JA, Emami B, et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int. J. Radiat. Oncol. Biol. Phys. 1999;45:323–329
  14. Hernando ML, Marks LB, Bentel GC, et al. Radiation-induced pulmonary toxicity: A dose-volume histogram analysis in 201 patients with lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 2001;51:650–659
  15. Marks LB, Munley MT, Bentel GC, et al. Physical and biological predictors of changes in whole-lung function following thoracic irradiation. Int. J. Radiat. Oncol. Biol. Phys. 1997;39:563–570
  16. Martel MK, Ten Haken RK, Hazuka MB, et al. Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis. Int. J. Radiat. Oncol. Biol. Phys. 1994;28:575–581
  17. Oetzel D, Schraube P, Hensley F, et al. Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis. Int. J. Radiat. Oncol. Biol. Phys. 1995;33:455–460
  18. Byhardt RW, Scott C, Sause WT, et al. Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung. Int. J. Radiat. Oncol. Biol. Phys. 1998;42:469–478
  19. Jeremic B, Shibamoto Y, Acimovic L, et al. Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small-cell lung cancer: A randomized study. J. Clin. Oncol. 1996;14:1065–1070
  20. Johansson S, Bjermer L, Franzen L, et al. Effects of ongoing smoking on the development of radiation-induced pneumonitis in breast cancer and oesophagus cancer patients. Radiother. Oncol. 1998;49:41–47
  21. Quon H, Shepherd FA, Payne DG, et al. The influence of age on the delivery, tolerance, and efficacy of thoracic irradiation in the combined modality treatment of limited stage small cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 1999;43:39–45
  22. Robnett TJ, Machtay M, Vines EF, et al. Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 2000;48:89–94
  23. Schaake-Koning C, van den Bogaert W, Dalesio O, et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N. Engl. J. Med. 1992;326:524–530
  24. Yamada M, Kudoh S, Hirata K, et al. Risk factors of pneumonitis following chemoradiotherapy for lung cancer. Eur. J. Cancer. 1998;34:71–75
  25. Rodrigues G, Lock M, D'Souza D, et al. Prediction of radiation pneumonitis by dose-volume histogram parameters in lung cancer--a systematic review. Radiother. Oncol. 2004;71:127–138
  26. Sailer SL, Rosenman JG, Symon JR, et al. The tetrad and hexad: Maximum beam separation as a starting point for noncoplanar 3D treatment planning: Prostate cancer as a test case. Int. J. Radiat. Oncol. Biol. Phys. 1994;30:439–446
  27. Belderbos J, Heemsbergen W, Hoogeman M, et al. Acute esophageal toxicity in non-small cell lung cancer patients after high dose conformal radiotherapy. Radiother. Oncol. 2005;75:157–164
  28. Giraud P, Cosset JM. Radiation toxicity to the heart: Physiopathology and clinical data. Bull. Cancer. 2004;91:147–153
  29. Feng-Ming K, James A, Hayman KA, et al. Dose escalation study in patients with non small cell lung cancer (NSCLC): Predictors for radiation pneumonitis and fibrosis. Int. J. Radiat. Oncol. Biol. Phys. 2006;65:1075–1086
  30. Tsujino K, Hirota S, Endo M, et al. Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 2003;55:110–115
  31. Gopal R, Starkschall G, Tucker SL, et al. Effects of radiotherapy and chemotherapy on lung function in patients with non-small-cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 2003;56:114–120
  32. Willner J, Jost A, Baier K, et al. A little to a lot or a lot to a little? An analysis of pneumonitis risk from dose-volume histogram parameters of the lung in patients with lung cancer treated with 3-D conformal radiotherapy. Strahlenther. Onkol. 2003;179:548–556
  33. Sherouse GW. A mathematical basis for selection of wedge angle and orientation. Med. Phys. 1993;20:1211–1218
  34. Weil MD, Roach M, Pickett B, et al. 3D conformal radiotherapy in the sagittal plane for centrally located thoracic tumors. Med. Dosim. 1995;20:11–14
  35. Derycke S, Van Duyse B, De Gersem W, et al. Non-coplanar beam intensity modulation allows large dose escalation in stage III lung cancer. Radiother. Oncol. 1997;45:253–261
  36. Bradley J, Graham MV, Winter K, et al. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 2005;61:318–328
  37. Schild S. Results of a phase I/II trial of concurrent chemotherapy and escalating doses of radiation for unresectable non small cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 2005;63:44–49
  38. Blackstock AW, Socinski MA, Bogart J, et al. Induction plus concurrent chemotherapy with high dose (74 Gy) 3-dimensional thoracic radiotherapy in stage III non small cell lung cancer (NSCLC): Preliminary report of the Cancer and Leukemia Group B (CALGB) 30105. J. Clin. Oncol (2006 ASCC Annual Meeting Proceedings Part 1). 2006;24(18S):7042;(June 20 Supplement)

PII: S0958-3947(09)00050-8

doi: 10.1016/j.meddos.2009.05.003

Medical Dosimetry
Volume 35, Issue 3 , Pages 169-178 , Autumn 2010

Article Tools

* Image Usage & Resolution